Meal composition effects on the oral bioavailability of indinavir in HIV-infected patients

被引:52
|
作者
Carver, PL
Fleisher, D
Zhou, SY
Kaul, D
Kazanjian, P
Li, C
机构
[1] Univ Michigan, Coll Pharm, Ann Arbor, MI 48109 USA
[2] Univ Michigan, Med Ctr, Dept Med, Div Infect Dis, Ann Arbor, MI 48109 USA
关键词
meal effect; food effect; indinavir; protease inhibitors; oral absorption;
D O I
10.1023/A:1018880726035
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Purpose. To study the influence of large-volume high-calorie protein, fat, and carbohydrate meals and a non-caloric hydroxypropylmethyl cellulose (HPMC) viscous meal on the oral bioavailability of indinavir in HIV-infected subjects. Methods. Seven male HIV-infected subjects received caloric meal treatments and control meals in a randomized crossover fashion and the viscosity meal as a final treatment. The total volume of each meal treatment was 500 mL and the caloric meals each contained 680 kcal. Gastric pH was also monitored by radiotelemetry from one hour before to four hours after drug and caloric meal administration. A single Crixivan(TM) (indinavir sulfate) dose equivalent to 600 mg indinavir was administrated orally with 100 mL of water immediately following meal administration. Indinavir plasma concentrations were obtained using reverse-phase HPLC. Results. All meal treatments significantly decreased the extent of indinavir absorption as compared to fasted control. AUC(0-infinity) decreased by 68%, 45%, 34%, and 30% for protein, carbohydrate, fat, and viscosity meal treatments versus fasted control, respectively (p < 0.05). The mean C-max was significantly decreased 74%, 59%, 46% and 36% (p < 0.05) and the mean t(max) was significantly delayed from 1 hr in fasted controls to 3.8, 3.6, 2.1 and 2.0 hrs (p < 0.05) for protein, carbohydrate, fat, and viscosity meal treatments, respectively. The elimination half-life of indinavir determined in the fasted state was decreased in HIV-infected subjects as compared to the reported half-life in normal healthy subjects. Conclusions. Reductions in indinavir plasma concentrations compared to drug administration in the fasted state are most severe with the high-calorie protein meal. This is consistent with an influence of elevated gastric pH on drug precipitation. Significant drug plasma concentration reductions observed with administration of the other meals in the absence of appreciably elevated gastric pH profile indicate that other factors are playing a role in the meal effects. The similarity in indinavir plasma profiles with protein and carbohydrate versus fat and viscosity suggests that the latter meals may reduce the impact of drug precipitation compared to the former meals.
引用
收藏
页码:718 / 724
页数:7
相关论文
共 50 条
  • [41] Body Composition and Metabolic Changes in HIV-Infected Patients
    Stanley, Takara L.
    Grinspoon, Steven K.
    JOURNAL OF INFECTIOUS DISEASES, 2012, 205 : S383 - S390
  • [42] Increased meal-induced oxidative stress in HIV-infected patients
    Walter, Mary F.
    Folch, Eric
    Mehta, Aneesh
    del Rio, Carlos
    Rimland, David
    Brown, W. V.
    Le, N-Anh
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2007, 27 (06) : E99 - E99
  • [43] Side effects and their burden on HIV-infected patients
    Ayyar, KA
    Jordan, JC
    Black, LK
    VALUE IN HEALTH, 2003, 6 (03) : 269 - 269
  • [44] Increased oral ganciclovir bioavailability in HIV-infected patients with chronic diarrhoea and wasting syndrome - a population pharmacokinetic study
    Mouly, S
    Aymard, G
    Tillement, JP
    Caulin, C
    Bergmann, JF
    Urien, S
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 51 (06) : 557 - 565
  • [45] Lopinavir/ritonavir vs. indinavir/ritonavir in antiretroviral naive HIV-infected patients: immunovirological outcome and side effects
    Bongiovanni, M
    Bini, T
    Chiesa, E
    Cicconi, P
    Adorni, F
    Monforte, AA
    ANTIVIRAL RESEARCH, 2004, 62 (01) : 53 - 56
  • [46] Pharmacokinetics and pharmacodynamics of indinavir with or without low-dose ritonavir in HIV-infected Thai patients
    Burger, D
    Boyd, M
    Duncombe, C
    Felderhof, M
    Mahanontharit, A
    Ruxrungtham, K
    Ubolyam, S
    Stek, M
    Cooper, D
    Lange, J
    Phanupak, P
    Reiss, P
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2003, 51 (05) : 1231 - 1238
  • [47] The absence of hyperbilirubinaemia is highly predictive of treatment failure in advanced HIV-infected patients treated with indinavir
    Nouts, C
    Bonarek, M
    Morlat, P
    Delevaux, I
    Bonnet, F
    Lacoste, D
    Bernard, N
    Beylot, J
    INTERNATIONAL JOURNAL OF STD & AIDS, 2001, 12 (01) : 29 - 33
  • [48] HIV-Infected Patients
    Krishnan, Amrita
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2009, 15 (01) : 142 - 145
  • [49] Effects of exercise training and metformin on body composition and cardiovascular indices in HIV-infected patients
    Driscoll, SD
    Meininger, GE
    Lareau, MT
    Dolan, SE
    Killilea, KM
    Hadigan, CM
    Lloyd-Jones, DM
    Klibanski, A
    Frontera, WR
    Grinspoon, SK
    AIDS, 2004, 18 (03) : 465 - 473
  • [50] Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients
    Villanueva-Millan, Maria J.
    Perez-Matute, Patricia
    Recio-Fernandez, Emma
    Lezana Rosales, Jose M.
    Oteo, Jose A.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2017, 20